Sisram Medical Ltd

Research Sisram Medical Ltd (1696.HK) on Bullrun: market cap HKD 852.35M, P/E 7.9, dividend yield 5.2%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is HKD 852.35M; P/E is 7.9; dividend yield is 5.2%.

Peer valuation comparison

Latest P/E is 7.91x versus a Healthcare sector median of 21.69x (63.5% below).

Latest dividend yield is 5.22% versus a Healthcare sector median of 2.41% (116.6% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 365.35MUSD 19.02MUSD 6.82M58.9%0.04USD 70.97MUSD 51.75MUSD 479.85M
FY2024USD 349.11MUSD 25.13MUSD 14.94M62.1%0.05USD 70.23MUSD 43.20MUSD 464.03M
FY2023USD 359.29MUSD 31.50MUSD 35.37M61.1%0.07USD 70.60MUSD 44.68MUSD 452.31M
FY2022USD 354.48MUSD 40.17M-USD 42.28M57.0%0.09USD 81.55MUSD 41.34MUSD 430.87M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18HKD 852.35M7.95.2%0.1

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.1 HKD, yield 5.2%.

YearDividends/share
FY20250.13 USD
FY20240.16 USD
FY20230.17 USD
FY20220.16 USD
FY20210.07 USD

About Sisram Medical Ltd

Sisram Medical Ltd, together with its subsidiaries, engages in the research, design, development, manufacture, sale, and marketing of medical aesthetics and dental equipment, home-use devices, injectables, and cosmeceutical products in the Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Sisram Medical Ltd's market cap?

Sisram Medical Ltd's market capitalization is HKD 852.35M.

What is Sisram Medical Ltd's P/E ratio?

Sisram Medical Ltd's price-to-earnings (P/E) ratio is 7.9.

Does Sisram Medical Ltd pay a dividend?

Sisram Medical Ltd has a dividend yield of 5.2%.

What does Sisram Medical Ltd do?

Sisram Medical Ltd, together with its subsidiaries, engages in the research, design, development, manufacture, sale, and marketing of medical aesthetics and dental equipment, home-use devices, injectables, and cosmeceutical products in the Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America.